Works matching AU Iurlo, Alessandra
Results: 155
Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 207, doi. 10.1007/s00277-024-06100-4
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Breakthrough infections in MPN-COVID vaccinated patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00749-8
- By:
- Publication type:
- Article
Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Long-term follow-up of recovered MPN patients with COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00445-z
- By:
- Publication type:
- Article
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0333-2
- By:
- Publication type:
- Article
Chronic Myeloid Leukemia Patient's Voice About the Experience of Treatment-Free Remission Failure: Results From the Italian Sub-Study of ENESTPath Exploring the Emotional Experience of Patients During Different Phases of a Clinical Trial.
- Published in:
- Frontiers in Psychology, 2019, p. N.PAG, doi. 10.3389/fpsyg.2019.00329
- By:
- Publication type:
- Article
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option.
- Published in:
- Clinical Drug Investigation, 2018, v. 38, n. 5, p. 475, doi. 10.1007/s40261-018-0623-7
- By:
- Publication type:
- Article
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-05028-9
- By:
- Publication type:
- Article
Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 12, p. e34, doi. 10.1016/j.clml.2024.08.009
- By:
- Publication type:
- Article
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 5, p. 323, doi. 10.1016/j.clml.2024.01.008
- By:
- Publication type:
- Article
CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S329, doi. 10.1016/S2152-2650(21)01772-9
- By:
- Publication type:
- Article
Poster: CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S225, doi. 10.1016/S2152-2650(21)01419-1
- By:
- Publication type:
- Article
Dropled Digital PCR May Have a Prognostic Value for Predicting Relapse after Imatinib Discontinuation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S62, doi. 10.1016/j.clml.2016.07.090
- By:
- Publication type:
- Article
Essential Thrombocythemia: The Dermatologic Point of View.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Biological Determinants of Long-Term Survival in Chronic Myelogenous Leukemia Patients Treated with Conventional Chemotherapy.
- Published in:
- Acta Haematologica, 1997, v. 97, n. 3, p. 187, doi. 10.1159/000203679
- By:
- Publication type:
- Article
Evans' Syndrome in Paroxysmal Nocturnal Hemoglobinuria.
- Published in:
- Acta Haematologica, 1985, v. 73, n. 4, p. 210, doi. 10.1159/000206330
- By:
- Publication type:
- Article
Molecular characterization of the PK-LR gene in sixteen pyruvate kinase-deficient patients.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 1, p. 43, doi. 10.1046/j.1365-2141.2001.02711.x
- By:
- Publication type:
- Article
Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2787, doi. 10.1007/s00277-024-05801-0
- By:
- Publication type:
- Article
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 437, doi. 10.1007/s00277-023-05577-9
- By:
- Publication type:
- Article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Pathological and genomic features of myeloproliferative neoplasms associated with splanchnic vein thrombosis in a single-center cohort.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1409, doi. 10.1007/s00277-023-05217-2
- By:
- Publication type:
- Article
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1375, doi. 10.1007/s00277-023-05159-9
- By:
- Publication type:
- Article
Effectiveness and management of ponatinib as second-line treatment in chronic myeloid leukemia: an analysis from the monitoring registries of the Italian medicines agency (AIFA).
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1257, doi. 10.1007/s00277-023-05168-8
- By:
- Publication type:
- Article
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA).
- Published in:
- Annals of Hematology, 2021, v. 100, n. 2, p. 481, doi. 10.1007/s00277-021-04406-1
- By:
- Publication type:
- Article
Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 8, p. 1885, doi. 10.1007/s00277-019-03705-y
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Identification and assessment of frailty in older patients with chronic myeloid leukemia and myelofibrosis, and indications for tyrosine kinase inhibitor treatment.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Reactive follicular hyperplasia on dasatinib treatment for chronic myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Clinical and morphologic features in five post-polycythemic myelofibrosis patients treated with ruxolitinib.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis.
- Published in:
- 2015
- By:
- Publication type:
- Letter
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 16, p. 5267, doi. 10.3390/jcm12165267
- By:
- Publication type:
- Article
Dose Optimization of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A New Therapeutic Challenge.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 3, p. 515, doi. 10.3390/jcm10030515
- By:
- Publication type:
- Article
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3692, doi. 10.3390/jcm9113692
- By:
- Publication type:
- Article
Prognostic significance of a comprehensive histological evaluation of reticulin fibrosis, collagen deposition and osteosclerosis in primary myelofibrosis patients.
- Published in:
- Histopathology, 2017, v. 71, n. 6, p. 897, doi. 10.1111/his.13309
- By:
- Publication type:
- Article
Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) Patients.
- Published in:
- Patient Preference & Adherence, 2022, v. 16, p. 2963, doi. 10.2147/PPA.S369326
- By:
- Publication type:
- Article
Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.
- Published in:
- Human Mutation, 2009, v. 30, n. 9, p. 1292, doi. 10.1002/humu.21077
- By:
- Publication type:
- Article
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 5, p. 1726, doi. 10.1002/cam4.3778
- By:
- Publication type:
- Article
How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)
- Published in:
- Cancer Medicine, 2020, v. 9, n. 12, p. 4160, doi. 10.1002/cam4.3071
- By:
- Publication type:
- Article
Immune Dysregulation and Infectious Complications in MPN Patients Treated With JAK Inhibitors.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.750346
- By:
- Publication type:
- Article